HEALWELL AI INC A SUB VTG - HWAIF STOCK NEWS

Welcome to our dedicated page for HEALWELL AI A SUB VTG news (Ticker: HWAIF), a resource for investors and traders seeking the latest updates and insights on HEALWELL AI A SUB VTG stock.

HEALWELL AI Inc. (HWAIF) is a healthcare technology company specializing in AI and data science for preventative care. Recently, the company participated in groundbreaking research on Chronic Kidney Disease (CKD) published in the American Journal of Kidney Diseases. HEALWELL's AI-powered clinical decision support technology aids Nephrologists in improving guideline-recommended testing for CKD patients. The company's second-generation AI Clinical Co-Pilot continues to enhance patient care. With the recent acquisition of BioPharma Services Inc., a top Contract Research Organization, HEALWELL expands its clinical research offerings, focusing on advancing patient-centered clinical trials and leveraging AI-driven recommendations to accelerate recruitment. HEALWELL aims to revolutionize preventative care and improve patient health outcomes through cutting-edge technology and strategic partnerships.

05/10/2024 07:00 AM

News

HEALWELL AI to Announce Fiscal First Quarter 2024 Financial Results on May 14, 2024

Rhea-AI Summary

HEALWELL AI Inc. will announce its Fiscal First Quarter 2024 financial results on May 14, 2024. The company focuses on preventative care and will hold a conference call and webcast to discuss the results, hosted by CEO Dr. Alexander Dobranowski and CFO Scott Nirenberski.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-3.03%

Tags

05/02/2024 08:00 AM

News

WELL Launches its Second-Generation AI powered Physician Co-pilot with Chronic Disease Detection Powered by HEALWELL AI

Rhea-AI Summary

WELL and HEALWELL AI have launched the second-generation WELL AI Decision Support (WAIDS) with advanced chronic disease screening capabilities, aiding in patient risk stratification. The tool identifies over 100 diseases, providing actionable insights at the point of care. Chronic diseases affect 45.1% of Canadians, costing the economy $190 billion annually.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

8.02%

Tags

04/17/2024 07:45 AM

News

HEALWELL Subsidiaries, Khure Health & Pentavere Research Group, to Participate and Present at Upcoming Globally Recognized Medical Conferences

Rhea-AI Summary

HEALWELL AI Inc. announces its subsidiaries, Khure Health & Pentavere Research Group, will present at major medical conferences in May 2024. Khure Health will showcase AI clinical decision support technology at the National Kidney Foundation Spring Clinical Meetings, while Pentavere will present AI research at various conferences. The conferences include the Canadian Retina Society Annual Meeting, American Head & Neck Society Annual Meeting, and American Medical Informatics Association Clinical Informatics Conference.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-12.21%

Tags

04/09/2024 07:07 AM

News

Emerging Markets Report: Follow the Leader

Rhea-AI Summary

Nvidia's focus on healthcare and AI showcases market interest in the intersection of these fields. HEALWELL AI Inc. (HWAIF) emerges as a key player in AI-driven preventative care solutions, with a revenue of $2.8 million in Q3-2023. Recent commercial agreements with WELL Health USA and Circle Medical signal significant growth opportunities for HEALWELL in the U.S. market.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-7.29%

Tags

04/04/2024 07:00 AM

News

HEALWELL AI’s Pentavere Achieves Validation of Generative AI for Preventative Care Through Landmark Publication

Rhea-AI Summary

HEALWELL AI Inc. announces a significant milestone with the publication of a peer-reviewed paper by its subsidiary Pentavere Research Group, validating the use of generative AI to identify rare lung cancer patients. This achievement showcases HEALWELL's leadership in developing AI technology applications in healthcare, supporting precision oncology efforts. The paper highlights the successful extraction of a large population cohort of advanced rare EGFRexon20 lung cancer patients for Real World Evidence, providing valuable insights into unmet patient needs and more effective cancer treatments.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

8.86%

Tags

04/03/2024 07:45 AM

News

HEALWELL AI to Participate in Upcoming Investor Conferences

Rhea-AI Summary

HEALWELL AI Inc. announces CEO participation in upcoming investor conferences, including LD Micro Invitational XIV, Bloom Burton & Co. Healthcare Investor Conference, and Planet MicroCap Showcase: VEGAS 2024.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-4.42%

Tags

03/28/2024 07:45 AM

News

HEALWELL AI Reports Q4 and Full Year 2023 Financial Results

Rhea-AI Summary

HEALWELL AI Inc. achieved annual revenue of $7.32 million in fiscal 2023, doubling its revenue run rate since Q4 2023 to over $20 million. The company's strategic alliance with WELL Health Technologies Inc. is thriving, leading to significant activities in Canada and the US. HEALWELL's financial results indicate growth potential with a positive outlook for doubling its revenue run-rate to over $40 million. The recent acquisitions and partnerships are positioning HEALWELL as a key player in AI and data science for healthcare.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

0.52%

Tags

03/27/2024 07:00 AM

News

HEALWELL AI to Announce Fourth Quarter and Year End 2023 Financial Results on March 28, 2024

Rhea-AI Summary

HEALWELL AI Inc. announces a conference call to discuss its Fiscal Fourth Quarter and Year End 2023 financial results on March 28, 2024. The call will be led by Dr. Alexander Dobranowski, CEO, and Scott Nirenberski, CFO.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-1.79%

Tags

03/26/2024 04:00 AM

News

HEALWELL AI’s Intrahealth Provides Update on New Customer Implementation with Toronto Public Health

Rhea-AI Summary

HEALWELL AI Inc. announces successful implementation of Intrahealth's EHR software with Toronto Public Health, strengthening its presence in the Ontario public health sector. Intrahealth, acquired by HEALWELL, is focusing on leveraging AI technology to enhance operational efficiency.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

1.05%

Tags

03/14/2024 07:00 AM

News

HEALWELL AI Announces New Commercial Agreements with WELL HEALTH USA and Circle Medical, Bringing AI-Based Preventative Care Solutions to U.S. Market

Rhea-AI Summary

HEALWELL AI expands its footprint in the U.S. through agreements with WELL Health USA and Circle Medical Technologies Inc. to provide AI-powered preventative care solutions. The partnerships aim to analyze U.S. clinical data for better patient support and earlier disease diagnosis.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

0.08%

Tags

FAQ

What is the current stock price of HEALWELL AI A SUB VTG (HWAIF)?

The current stock price of HEALWELL AI A SUB VTG (HWAIF) is $1.17 as of September 6, 2024.

What is the market cap of HEALWELL AI A SUB VTG (HWAIF)?

The market cap of HEALWELL AI A SUB VTG (HWAIF) is approximately 228.1M.

What is HEALWELL AI Inc.?

HEALWELL AI Inc. is a healthcare technology company focused on AI and data science for preventative care.

What recent research has HEALWELL AI Inc. participated in?

HEALWELL AI Inc. recently participated in research on Chronic Kidney Disease (CKD) published in the American Journal of Kidney Diseases.

What is the focus of HEALWELL's AI-powered technology?

HEALWELL's AI-powered technology aids Nephrologists in improving guideline-recommended testing for CKD patients and enhances patient care.

What recent acquisition has HEALWELL made?

HEALWELL recently acquired BioPharma Services Inc., a leading Contract Research Organization specializing in early clinical trials.

What is HEALWELL's goal with the acquisition of BioPharma Services Inc.?

HEALWELL aims to expand its clinical research capabilities, focusing on patient-centered clinical trials and leveraging AI-driven recommendations to accelerate recruitment.

How does HEALWELL plan to revolutionize healthcare?

HEALWELL aims to revolutionize preventative care and improve patient health outcomes through cutting-edge technology and strategic partnerships.

What sectors does HEALWELL specialize in?

HEALWELL specializes in AI and data science for healthcare, with a focus on preventative care and clinical research.

What is the significance of HEALWELL's research on Chronic Kidney Disease?

HEALWELL's research on Chronic Kidney Disease published in the American Journal of Kidney Diseases highlights the impact of advanced technology in supporting improved patient care for chronic diseases.

How does HEALWELL plan to utilize AI technology in healthcare?

HEALWELL plans to leverage AI technology to improve patient care, accelerate recruitment for clinical trials, and enhance healthcare outcomes.

What partnerships has HEALWELL established for research and development?

HEALWELL has partnered with reputable organizations like BioPharma Services Inc. for expanding its clinical research capabilities and advancing patient-centered care.

What benefits can patients and healthcare providers expect from HEALWELL's technology?

Patients and healthcare providers can expect improved care, accelerated recruitment for clinical trials, and enhanced healthcare outcomes through HEALWELL's cutting-edge technology and AI-driven solutions.